Trial
NCT01546883
Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Utah
Collaborators
—
Condition
Atrial Fibrillation
Intervention
Dabigatran etexilate (Pradaxa)
Why stopped
Not enough patients in time period allotted for study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-12